CAR-T cells - International Biopharmaceutical Industry

Current Edition

news

Gilead’s Kite Exits China Cell Therapy Joint Venture with Fosun Pharma

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the 50-50 cell-therapy-focused joint venture wi...

23 September 2024 news CAR-T cells | Cell and Gene Therapy

Continue Reading →

Volume 4 Issue 3

Are We Nearly There Yet? The Ongoing Journey of CAR-T Cell Therapies

CAR-T cells have a genetically engineered T-cell receptor (TCR) that directs their binding to cancer cells. In first-generation CARs, the TCR was engineered to expres...